Publications by authors named "Elham S Al-Risi"
Antimicrobial Resistance Pattern, Predisposing Factors, and Outcome of Serratia Infection in Patients Treated at a Secondary-Care Hospital in Oman: A 5-Year Retrospective Study.
Adv Biomed Res
October 2024
Background: has emerged as an important nosocomial opportunistic pathogen, often associated with serious infections. We investigated the antimicrobial resistance trends, predisposing factors, and infection outcomes associated with isolated in a secondary-care hospital in Oman.
Materials And Methods: A retrospective study was conducted at a secondary-care hospital in the northern region of Oman after receiving approval from the research ethics and approval committee of Oman.
Article Synopsis
- Hepatitis C virus (HCV) is a significant public health issue mainly spread through infected blood, and a study in Oman sought to uncover risk factors for its transmission and chronic impacts.* -
- Conducted at a secondary-care hospital from 2017 to 2022, the study analyzed 177 confirmed HCV cases, primarily among males aged 21-60, revealing major transmission risks like hemodialysis, blood transfusions, and injection drug use.* -
- Findings highlighted that HCV can lead to serious health complications, stressing the need for increased community awareness and preventive measures regarding HCV transmission.*
Incidence of secondary bacterial infections and risk factors for in-hospital mortality among coronavirus disease 2019 subjects admitted to secondary care hospital: A single-center cross-sectional retrospective study.
Int J Crit Illn Inj Sci
June 2024
Background: This study aims to determine the prevalence of secondary bacterial infections (SBIs) in hospitalized coronavirus disease 2019 (COVID-19) subjects and evaluate their antibiotic susceptibility. The study also sought to identify risk factors for the outcome of SBIs in COVID-19 subjects.
Methods: This single-center cross-sectional retrospective study was carried out at Sohar Hospital in Oman.
Objectives: To evaluate the significance of serum chromogranin A (CgA) status in patients with and without different neuroendocrine tumors (NETs) by conducting a retrospective assessment of the diagnostic utility and limitations of CgA as a biomarker for NETs in a tertiary care hospital in Oman.
Methods: We conducted a retrospective analysis of CgA requests referred to the Clinical Biochemistry Laboratory, Royal Hospital, Oman over a 24-month period (April 2012 to March 2014). During this time, 302 CgA tests for 270 patients (119 males and 151 females; age range 11-86 years and mean±standard deviation (SD) 44.